These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8775819)

  • 1. [Pathology of the heart transplant].
    Sánchez-Vegazo I; Sanz E; Anaya A
    Rev Esp Cardiol; 1995; 48 Suppl 7():65-70. PubMed ID: 8775819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathology of cardiac transplantation--the initial experience.
    Chopra P; Joshi A; Talwar KK; Airan B; Srivastava S; Venugopal P
    Natl Med J India; 1997; 10(6):264-9. PubMed ID: 9481095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine surveillance myocardial biopsies are unnecessary beyond one year after heart transplantation.
    White JA; Guiraudon C; Pflugfelder PW; Kostuk WJ
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1052-6. PubMed ID: 8719450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathology of heart transplantation.(Morphological study of 1246 endomyocardial biopsies from 167 transplanted hearts). Causes of early, intermediate, and late deaths].
    Agozzino L; Thomopoulos K; Esposito S; Agozzino M; De Vivo F; Maiello C; Cotrufo M
    Pathologica; 1999 Apr; 91(2):89-100. PubMed ID: 10484868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unsuspected rejection episodes on routine surveillance endomyocardial biopsy post-heart transplant in paediatric patients.
    Dixon V; Macauley C; Burch M; Sebire NJ
    Pediatr Transplant; 2007 May; 11(3):286-90. PubMed ID: 17430484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consistencies and controversies in the application of the International Society for Heart and Lung Transplantation working formulation for heart transplant biopsy specimens. Rapamycin Cardiac Rejection Treatment Trial Pathologists.
    Winters GL; McManus BM
    J Heart Lung Transplant; 1996 Jul; 15(7):728-35. PubMed ID: 8820790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microfocal myocardial lesions in cardiac allograft recipients.
    Frasik W; Lazar A; Garlicki M; Wysocka T; Kozanecki A; Dziatkowiak A
    Pol J Pathol; 1994; 45(2):117-27. PubMed ID: 8062063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological findings in cardiac transplant recipients: an assessment after 10 years' experience in Iran.
    Ghadimi H; Tavangar SM
    Transplant Proc; 2005 Dec; 37(10):4535-6. PubMed ID: 16387163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quilty in biopsy is associated with poor prognosis after heart transplantation.
    Hiemann NE; Knosalla C; Wellnhofer E; Lehmkuhl HB; Hetzer R; Meyer R
    Transpl Immunol; 2008 Jul; 19(3-4):209-14. PubMed ID: 18617005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A critical review of the role of endomyocardial biopsy in heart transplantation].
    Vázquez de Prada JA
    Rev Esp Cardiol; 1995; 48 Suppl 7():86-91. PubMed ID: 8775822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is it necessary to perform surveillance endomyocardial biopsies in heart transplant recipients?
    Sethi GK; Kosaraju S; Arabia FA; Roasdo LJ; McCarthy MS; Copeland JG
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1047-51. PubMed ID: 8719449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endomyocardial biopsy. Pathologic findings in cardiac transplant recipients.
    Kottke-Marchant K; Ratliff NB
    Pathol Annu; 1990; 25 Pt 1():211-44. PubMed ID: 2404245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nature and significance of epicardial lymphoid infiltrates in cardiac allografts.
    Luthringer DJ; Yamashita JT; Czer LS; Trento A; Fishbein MC
    J Heart Lung Transplant; 1995; 14(3):537-43. PubMed ID: 7654737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute rejection and heart infection rates in FK 506- versus cyclosporine A-treated heart transplant recipients: an endomyocardial biopsy pathologic study.
    Arbustini E; Dal Bello B; Rinaldi M; Diegoli M; Grasso M; Pellegrini C; Morbini P; Martinelli L; Bonora MR; Viganò M
    J Heart Lung Transplant; 1997 Sep; 16(9):982-4. PubMed ID: 9322152
    [No Abstract]   [Full Text] [Related]  

  • 15. Should we be doing routine biopsy after heart transplantation in a new era of anti-rejection?
    Patel JK; Kobashigawa JA
    Curr Opin Cardiol; 2006 Mar; 21(2):127-31. PubMed ID: 16470149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology of heart transplant through endomyocardial biopsy.
    Pardo-Mindán FJ; Lozano MD; Contreras-Mejuto F; de Alava E
    Semin Diagn Pathol; 1992 Aug; 9(3):238-48. PubMed ID: 1523362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum and diagnosis of myocardial rejection.
    Tazelaar HD
    Cardiol Clin; 1990 Feb; 8(1):119-39. PubMed ID: 2407354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of Quilty lesion in cardiac allografts: relationship to reduced endocardial cyclosporine A.
    Freimark D; Czer LS; Aleksic I; Ruan XM; Admon D; Blanche C; Trento A; Fishbein MC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1197-203. PubMed ID: 8719467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac transplantation: role of endomyocardial biopsy and immunosuppressive agents.
    Eiswirth CC; Smart FW
    J La State Med Soc; 1993 May; 145(5):203-6. PubMed ID: 8340682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients.
    Marboe CC; Billingham M; Eisen H; Deng MC; Baron H; Mehra M; Hunt S; Wohlgemuth J; Mahmood I; Prentice J; Berry G
    J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S219-26. PubMed ID: 15993777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.